DM
SWTX

Deerfield Management’s SpringWorks Therapeutics SWTX Stock Holding History

Deerfield Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,283,176
Closed -$63.2M – 557
2024
Q1 		$63.2M Sell
1,283,176
-1,301,200
-50% -$60.2M 1.1% 24
2023
Q4 		$94.3M Buy
2,584,376
+1,004,802
+64% +$26.2M 1.74% 15
2023
Q3 		$36.5M Buy
1,579,574
+225
+0% +$6.15K 0.8% 33
2023
Q2 		$41.4M Hold
1,579,349
– – 0.88% 31
2023
Q1 		$40.7M Buy
1,579,349
+546,349
+53% +$16M 0.91% 34
2022
Q4 		$26.9M Buy
1,033,000
+216,006
+26% +$5.32M 0.56% 52
2022
Q3 		$23.3M Buy
+816,994
New +$23.4M 0.46% 59
2022
Q2 		– Sell
-249,988
Closed -$14.1M – 134
2022
Q1 		$14.1M Sell
249,988
-202,012
-45% -$11.6M 0.32% 63
2021
Q4 		$28M Sell
452,000
-58,673
-11% -$3.88M 0.59% 46
2021
Q3 		$32.4M Sell
510,673
-47,901
-9% -$3.69M 0.63% 48
2021
Q2 		$46M Hold
558,574
– – 0.82% 38
2021
Q1 		$41.1M Sell
558,574
-884,396
-61% -$69.3M 0.86% 39
2020
Q4 		$105M Buy
1,442,970
+208,708
+17% +$13.4M 2.07% 11
2020
Q3 		$58.8M Hold
1,234,262
– – 1.43% 22
2020
Q2 		$51.8M Buy
1,234,262
+446,019
+57% +$15.9M 1.51% 19
2020
Q1 		$21.3M Hold
788,243
– – 0.68% 47
2019
Q4 		$30.3M Sell
788,243
-262,645
-25% -$6.15M 0.97% 33
2019
Q3 		$22.8M Buy
+1,050,888
New +$24.8M 0.93% 36

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Deerfield Management's SWTX Position: Q2 2024 in Review

Deerfield Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2024, closing a stake of 1,283,176 shares — an estimated $63.2M sold.

Deerfield Management first reported a position in SWTX in Q3 2019 and held it in 18 quarters. The position peaked at $105M in Q4 2020. 209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

  • Deerfield Management reported no remaining SpringWorks Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 1,283,176 SpringWorks Therapeutics shares in Q2 2024, an estimated $63.2M.
  • Deerfield Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 18 quarters.
  • Deerfield Management's SpringWorks Therapeutics position peaked at $105M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.